BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17158653)

  • 1. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction.
    Bergman MR; Teerlink JR; Mahimkar R; Li L; Zhu BQ; Nguyen A; Dahi S; Karliner JS; Lovett DH
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1847-60. PubMed ID: 17158653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
    Zavadzkas JA; Plyler RA; Bouges S; Koval CN; Rivers WT; Beck CU; Chang EI; Stroud RE; Mukherjee R; Spinale FG
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1394-402. PubMed ID: 18689500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility.
    Wang GY; Bergman MR; Nguyen AP; Turcato S; Swigart PM; Rodrigo MC; Simpson PC; Karliner JS; Lovett DH; Baker AJ
    Cardiovasc Res; 2006 Feb; 69(3):688-96. PubMed ID: 16183043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
    Voloshenyuk TG; Gardner JD
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
    Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous ubiquitin modulates chronic β-adrenergic receptor-stimulated myocardial remodeling: role in Akt activity and matrix metalloproteinase expression.
    Daniels CR; Foster CR; Yakoob S; Dalal S; Joyner WL; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2012 Dec; 303(12):H1459-68. PubMed ID: 23042947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.
    Zile MR; Baicu CF; Stroud RE; Van Laer AO; Jones JA; Patel R; Mukherjee R; Spinale FG
    Circ Heart Fail; 2014 Mar; 7(2):340-50. PubMed ID: 24395927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure.
    Song YH; Li BS; Chen XM; Cai H
    Int J Mol Med; 2008 Jan; 21(1):117-24. PubMed ID: 18097624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
    Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
    Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
    Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
    Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
    J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction.
    Vinet L; Rouet-Benzineb P; Marniquet X; Pellegrin N; Mangin L; Louedec L; Samuel JL; Mercadier JJ
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H352-60. PubMed ID: 18487442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
    Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
    Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.
    Zile MR; Baicu CF; Stroud RE; Van Laer A; Arroyo J; Mukherjee R; Jones JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1429-37. PubMed ID: 22287584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
    Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
    Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation.
    Kitaoka H; Kubo T; Okawa M; Takenaka N; Baba Y; Yamasaki N; Matsumura Y; Furuno T; Doi YL
    J Cardiol; 2011 Nov; 58(3):261-5. PubMed ID: 21890325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.